IgA nephropathy screening: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Tarek Nafee (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{IgA nephropathy}} | |||
{{CMG}}; {{APM}} {{AE}}{{OO}} | |||
==Overview== | |||
==Screening== | ==Screening== | ||
According to the "National Kidney Foundation: Kidney Disease - Improving Global Outcomes" (NKF-KDIGO) guidelines for glomerulonephritis<ref name="pmid22895519">{{cite journal| author=Radhakrishnan J, Cattran DC| title=The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. | journal=Kidney Int | year= 2012 | volume= 82 | issue= 8 | pages= 840-56 | pmid=22895519 | doi=10.1038/ki.2012.280 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22895519 }} </ref>, screening is currently not recommended for IgA nephropathy. | According to the "National Kidney Foundation: Kidney Disease - Improving Global Outcomes" (NKF-KDIGO) guidelines for glomerulonephritis<ref name="pmid22895519">{{cite journal| author=Radhakrishnan J, Cattran DC| title=The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. | journal=Kidney Int | year= 2012 | volume= 82 | issue= 8 | pages= 840-56 | pmid=22895519 | doi=10.1038/ki.2012.280 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22895519 }} </ref>, screening is currently not recommended for IgA nephropathy. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}}{{WS}} | |||
Revision as of 00:02, 4 November 2016
IgA nephropathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
IgA nephropathy screening On the Web |
American Roentgen Ray Society Images of IgA nephropathy screening |
Risk calculators and risk factors for IgA nephropathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2] Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]
Overview
Screening
According to the "National Kidney Foundation: Kidney Disease - Improving Global Outcomes" (NKF-KDIGO) guidelines for glomerulonephritis[1], screening is currently not recommended for IgA nephropathy.
References
- ↑ Radhakrishnan J, Cattran DC (2012). "The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient". Kidney Int. 82 (8): 840–56. doi:10.1038/ki.2012.280. PMID 22895519.